Lymphocyte glucocorticoid receptors in asthmatic and control subjects

B. S. Tsai, G. Watt, K. Koesnadi, R. G. Townley

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Glucocorticoid hormones, which are widely used in the treatment of asthma, have been shown to potentiate physiological and biochemical beta-adrenergic responsiveness in asthmatics. These effects are presumably mediated through glucocorticoid receptors. In order to better understand glucocorticoid pharmacology in asthmatics, we assayed glucocorticoid receptors by directly binding a radioactively labelled glucocorticoid hormone, dexamethasone, to intact lymphocytes prepared from the peripheral blood of asthmatics and control subjects. Binding studies were performed with dexamethasone at 100 nM and 5 nM concentrations. At 100 nM dexamethasone, the mean number of lymphocyte glucocorticoid receptors (per cell) in control subjects (7191 ± 385, n = 9) was not significantly different from that in asthmatic subjects (7772 ± 437, n =9). At 5 nM dexamethasone, the mean number of glucocorticoid receptors in control subjects (1177 ± 194, n=5) was not significantly different from that in asthmatic subjects (1215 ± 108, n=8). At 100 nM dexamethasone, males had significantly more receptors (7939 ± 360, n=11) than females (6764 ± 72, n=7). Our results suggest that the number of lymphocyte glucocorticoid receptors and the apparent affinity of dexamethasone for receptors are not related to the presence or severity of asthma; however, a significant sex effect exists which should be corrected for in future studies of lymphocyte glucocorticoid receptors.

Original languageEnglish
Pages (from-to)363-371
Number of pages9
JournalClinical Allergy
Volume14
Issue number4
DOIs
StatePublished - 1984

Fingerprint

Glucocorticoid Receptors
Dexamethasone
Lymphocytes
Glucocorticoids
Lymphocyte Count
Asthma
Hormones
Adrenergic Agents
Pharmacology

All Science Journal Classification (ASJC) codes

  • Immunology
  • Immunology and Allergy

Cite this

Lymphocyte glucocorticoid receptors in asthmatic and control subjects. / Tsai, B. S.; Watt, G.; Koesnadi, K.; Townley, R. G.

In: Clinical Allergy, Vol. 14, No. 4, 1984, p. 363-371.

Research output: Contribution to journalArticle

Tsai, B. S. ; Watt, G. ; Koesnadi, K. ; Townley, R. G. / Lymphocyte glucocorticoid receptors in asthmatic and control subjects. In: Clinical Allergy. 1984 ; Vol. 14, No. 4. pp. 363-371.
@article{15d0f80dbc604ec58359111031e71ee9,
title = "Lymphocyte glucocorticoid receptors in asthmatic and control subjects",
abstract = "Glucocorticoid hormones, which are widely used in the treatment of asthma, have been shown to potentiate physiological and biochemical beta-adrenergic responsiveness in asthmatics. These effects are presumably mediated through glucocorticoid receptors. In order to better understand glucocorticoid pharmacology in asthmatics, we assayed glucocorticoid receptors by directly binding a radioactively labelled glucocorticoid hormone, dexamethasone, to intact lymphocytes prepared from the peripheral blood of asthmatics and control subjects. Binding studies were performed with dexamethasone at 100 nM and 5 nM concentrations. At 100 nM dexamethasone, the mean number of lymphocyte glucocorticoid receptors (per cell) in control subjects (7191 ± 385, n = 9) was not significantly different from that in asthmatic subjects (7772 ± 437, n =9). At 5 nM dexamethasone, the mean number of glucocorticoid receptors in control subjects (1177 ± 194, n=5) was not significantly different from that in asthmatic subjects (1215 ± 108, n=8). At 100 nM dexamethasone, males had significantly more receptors (7939 ± 360, n=11) than females (6764 ± 72, n=7). Our results suggest that the number of lymphocyte glucocorticoid receptors and the apparent affinity of dexamethasone for receptors are not related to the presence or severity of asthma; however, a significant sex effect exists which should be corrected for in future studies of lymphocyte glucocorticoid receptors.",
author = "Tsai, {B. S.} and G. Watt and K. Koesnadi and Townley, {R. G.}",
year = "1984",
doi = "10.1111/j.1365-2222.1984.tb02217.x",
language = "English",
volume = "14",
pages = "363--371",
journal = "Clinical and Experimental Allergy",
issn = "0954-7894",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Lymphocyte glucocorticoid receptors in asthmatic and control subjects

AU - Tsai, B. S.

AU - Watt, G.

AU - Koesnadi, K.

AU - Townley, R. G.

PY - 1984

Y1 - 1984

N2 - Glucocorticoid hormones, which are widely used in the treatment of asthma, have been shown to potentiate physiological and biochemical beta-adrenergic responsiveness in asthmatics. These effects are presumably mediated through glucocorticoid receptors. In order to better understand glucocorticoid pharmacology in asthmatics, we assayed glucocorticoid receptors by directly binding a radioactively labelled glucocorticoid hormone, dexamethasone, to intact lymphocytes prepared from the peripheral blood of asthmatics and control subjects. Binding studies were performed with dexamethasone at 100 nM and 5 nM concentrations. At 100 nM dexamethasone, the mean number of lymphocyte glucocorticoid receptors (per cell) in control subjects (7191 ± 385, n = 9) was not significantly different from that in asthmatic subjects (7772 ± 437, n =9). At 5 nM dexamethasone, the mean number of glucocorticoid receptors in control subjects (1177 ± 194, n=5) was not significantly different from that in asthmatic subjects (1215 ± 108, n=8). At 100 nM dexamethasone, males had significantly more receptors (7939 ± 360, n=11) than females (6764 ± 72, n=7). Our results suggest that the number of lymphocyte glucocorticoid receptors and the apparent affinity of dexamethasone for receptors are not related to the presence or severity of asthma; however, a significant sex effect exists which should be corrected for in future studies of lymphocyte glucocorticoid receptors.

AB - Glucocorticoid hormones, which are widely used in the treatment of asthma, have been shown to potentiate physiological and biochemical beta-adrenergic responsiveness in asthmatics. These effects are presumably mediated through glucocorticoid receptors. In order to better understand glucocorticoid pharmacology in asthmatics, we assayed glucocorticoid receptors by directly binding a radioactively labelled glucocorticoid hormone, dexamethasone, to intact lymphocytes prepared from the peripheral blood of asthmatics and control subjects. Binding studies were performed with dexamethasone at 100 nM and 5 nM concentrations. At 100 nM dexamethasone, the mean number of lymphocyte glucocorticoid receptors (per cell) in control subjects (7191 ± 385, n = 9) was not significantly different from that in asthmatic subjects (7772 ± 437, n =9). At 5 nM dexamethasone, the mean number of glucocorticoid receptors in control subjects (1177 ± 194, n=5) was not significantly different from that in asthmatic subjects (1215 ± 108, n=8). At 100 nM dexamethasone, males had significantly more receptors (7939 ± 360, n=11) than females (6764 ± 72, n=7). Our results suggest that the number of lymphocyte glucocorticoid receptors and the apparent affinity of dexamethasone for receptors are not related to the presence or severity of asthma; however, a significant sex effect exists which should be corrected for in future studies of lymphocyte glucocorticoid receptors.

UR - http://www.scopus.com/inward/record.url?scp=0021282272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021282272&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2222.1984.tb02217.x

DO - 10.1111/j.1365-2222.1984.tb02217.x

M3 - Article

VL - 14

SP - 363

EP - 371

JO - Clinical and Experimental Allergy

JF - Clinical and Experimental Allergy

SN - 0954-7894

IS - 4

ER -